Brevan Howard Capital Management »

Ultragenyx Pharmaceutical shares owned by Brevan Howard Capital Management

Quarter-by-quarter ownership of Ultragenyx Pharmaceutical (RARE) shares owned by Brevan Howard Capital Management from 13F filings

Historical chart of Brevan Howard Capital Management investment in Ultragenyx Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Ultragenyx Pharmaceutical held by Brevan Howard Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ultragenyx Pharmaceutical by Brevan Howard Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.0M 67k 30.08
2025-06-30 $297k 8.2k 36.36
2024-12-31 $1.5M 35k 42.07
2024-09-30 $902k 16k 55.55
2024-03-31 $424k 9.1k 46.69

More positions owned by Brevan Howard Capital Management

Alphabet Cap Stk Cl C Call Option (GOOG)
Ishares Bitcoin Trust Etf Shs Ben Int Call Option (IBIT)
Pdd Holdings Sponsored Ads Call Option (PDD)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Ishares Tr Msci Emg Mkt Etf Call Option (EEM)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Ishares Tr Iboxx Inv Cp Etf Call Option (LQD)
Dbx Etf Tr Xtrack Hrvst Csi Call Option (ASHR)
NVIDIA Corporation Call Option (NVDA)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Coinbase Global Com Cl A Call Option (COIN)
Baidu Spon Adr Rep A Call Option (BIDU)
Agnico Call Option (AEM)
Alphabet Cap Stk Cl A Put Option (GOOGL)

View all positions for Brevan Howard Capital Management

Top funds holding Ultragenyx Pharmaceutical

Vanguard Group
FMR
BlackRock
Jpmorgan Chase & Co
Sands Capital Management
State Street Corporation
Rtw Investments
Baker Bros. Advisors
Jacobs Levy Equity Management
Suvretta Capital Management
Wellington Management Company
Geode Capital Management
Deutsche Bank Aktiengesellschaft
Bnp Paribas Investment Partners
Pictet Asset Management Holding SA

View all funds holding Ultragenyx Pharmaceutical